Taiwan News7h
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for ...
Taiwan News11h
CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference
The data set from the double-blind phase of the RewinD-LB trial presented today at ILBDC is now accessible in the Investor section of the CervoMed website https://www.cervomed.com/.
SheerLuxe12h
The Hot List: January
The LuxeGen Hot List is our edit of new and noteworthy drops, campaigns, products and more – designed to keep you up to date with what’s going on in the worlds of fashion, beauty and culture. Here’s ...
Pharmabiz11h
Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan
Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan: Tokyo, Japan Friday, January 31, 2025, 18:00 Hrs [IST] Re ...
Economic Survey 2025 Live Updates: GDP Growth Pegged At 6.3-6.8%, Inflation To Stay Under Control, Says Survey
Economic Survey 2025 will be presented by Nirmala Sitharaman on Friday, January 31, ahead of the 2025 Union Budget ...
Yahoo Finance1d
Lifeway Foods, Inc. (LWAY)
After hours: January 27 at 4:09:33 PM EST Loading Chart for LWAY ...